Table 1 Summary of patient demographics, follow-up and lesion location
Paper | Level of evidence | Patients | M/F | Location of lesion, medial/lateral | Mean follow-up (months) | Mean patient age | |
|---|---|---|---|---|---|---|---|
Actifit | Leroy et al. [14] | IV | 15 | 7/8 | 6/9 | 72 | 30 |
Dhollander et al. [15] | IV | 44 | 24/20 | 29/15 | 60* | 32.13 | |
Toanen et al. [16] | IV | 155 | 109/46 | 101/54 | 60* | 33.7 | |
Monllau et al. [17] | IV | 32 | 25/7 | 21/11 | 70.2 | 41.3 | |
Filardo et al. [18] | IV | 16 | 9/7 | 12/4 | 72 | 45 | |
Total | 262 | 174/88 | 169/93 | ||||
Means | 66.8 | 36 | |||||
CMI | Zaffagnini et al. [19] | II | 17 | 17/0 | 17/0 | 135 | 38 |
Steadman et al. [20] | IV | 8 | 8/0 | 8/0 | 69.6 | 40 | |
Zaffagnini et al. [21] | IV | 8 | 8/0 | 8/0 | 81.6 | 31 | |
Bulgheroni et al. [22] | III | 17 | 13/4 | 17/0 | 116.4 | 32.9 | |
Bulgheroni et al. [23] | IV | 34 | 25/9 | 34/0 | 60* | 39 | |
Monllau et al. [24] | IV | 25 | 20/5 | 25/0 | 120* | 29.2 | |
Total | 109 | 91/18 | 109/0 | ||||
Means | 97.1 | 35 | |||||
NUsurface | McKeon et al. [11] | II | 65 | 41/24 | 65/0 | 12 | 48.7 |